4-Chloro-6,7-dimethoxyquinazoline - CAS 13790-39-1
Catalog: |
BB008669 |
Product Name: |
4-Chloro-6,7-dimethoxyquinazoline |
CAS: |
13790-39-1 |
Synonyms: |
4-chloro-6,7-dimethoxyquinazoline; 4-chloro-6,7-dimethoxyquinazoline |
IUPAC Name: | 4-chloro-6,7-dimethoxyquinazoline |
Description: | A useful synthetic intermediate in the preparation of epidermal growth factors. |
Molecular Weight: | 224.64 |
Molecular Formula: | C10H9ClN2O2 |
Canonical SMILES: | COC1=C(C=C2C(=C1)C(=NC=N2)Cl)OC |
InChI: | InChI=1S/C10H9ClN2O2/c1-14-8-3-6-7(4-9(8)15-2)12-5-13-10(6)11/h3-5H,1-2H3 |
InChI Key: | LLLHRNQLGUOJHP-UHFFFAOYSA-N |
Boiling Point: | 345.5 °C at 760 mmHg |
Density: | 1.321 g/cm3 |
Storage: | Keep in dark place, Sealed in dry, Room Temperature |
MDL: | MFCD01570172 |
LogP: | 2.30040 |
GHS Hazard Statement: | H302 (14.29%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113264889-A | Method suitable for industrial production and preparation of gefitinib | 20210611 |
CN-113004210-A | Quinazoline-4-selenium salt compound, preparation method and biological activity | 20210329 |
CN-112209888-A | 4-arylmercapto quinazoline compound, preparation method and medical application | 20201014 |
CN-112300141-A | Quinazoline-containing myricetin derivative, and preparation method and application thereof | 20201012 |
US-2021253556-A1 | Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (enpp1) and methods of use thereof | 20200204 |
PMID | Publication Date | Title | Journal |
21478021 | 20110501 | Metabolic stability of 6,7-dialkoxy-4-(2-, 3- and 4-[18F]fluoroanilino)quinazolines, potential EGFR imaging probes | Bioorganic & medicinal chemistry |
21033670 | 20101125 | Design, synthesis, and DNA-binding of N-alkyl(anilino)quinazoline derivatives | Journal of medicinal chemistry |
Complexity: | 218 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 224.0352552 |
Formal Charge: | 0 |
Heavy Atom Count: | 15 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 224.0352552 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 44.2 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinazolines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS